Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...
People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback